Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

BACKGROUND: EGFR mutation is a strong predictive factor of EGFR-TKIs therapy. However, at least 10% of patients with EGFR wild-type are responsive to TKIs, suggesting that other determinants of outcome besides EGFR mutation might exist. We hypothesized that activation of phosphorylated EGFR could be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Wang, Fen, Wang, Shuhang, Wang, Zhijie, Duan, Jianchun, An, Tongtong, Zhao, Jun, Bai, Hua, Wang, Jie
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3548765/
https://ncbi.nlm.nih.gov/pubmed/22901364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-31-65
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados